Indian CDMOs expand capacities with Syngene taking the lead
Biopharma manufacturing turbulence boosts inquiries for India-based providers
Navigating the Pharma Landscape
AI and ML is changing the game of drug discovery
Formula for Success
Syngene: Weak funding environment leads to a soft patch
Healthcare demand drivers remain intact: Syngene MD
The nitty gritty of biotherapeutics production
Syngene eyes sweet spot as new modalities hog limelight
Syngene COO Bhalgat expects earnings growth to pick up from Jan-Mar
